Literature DB >> 29432919

YAP1 is essential for osteoclastogenesis through a TEADs-dependent mechanism.

Liming Zhao1, Hanfeng Guan1, Chao Song1, Yuting Wang1, Changyu Liu1, Cong Cai1, Hao Zhu1, Hui Liu1, Libo Zhao2, Jun Xiao3.   

Abstract

Yes-associated protein 1 (YAP1), the core effector of the Hippo signaling pathway, has been identified as a key regulator of tissue homeostasis and organ development by controlling cell proliferation and differentiation. Previous studies have shown that YAP1 regulates multiple steps during skeletal development and bone remodeling, including the self-renewal and differentiation of mesenchymal stem cells (MSCs). However, its role in osteoclastogenesis remains largely unknown. Here, we report that YAP1 is an essential regulator for osteoclast differentiation and activity. Both mRNA and protein levels of YAP1 were downregulated during RANKL-induced osteoclastogenesis. Short hairpin RNA-mediated knockdown of YAP1 in bone marrow-derived macrophages (BMM) prevented the formation and function of multinucleated osteoclasts, and markedly abrogated the expression of osteoclast marker genes. Furthermore, the suppression of osteoclastogenesis and bone resorption activity were also observed in the BMM treated with verteporfin, a small molecule that inhibits the association of YAP1 with the transcriptional enhancer-associated domain (TEAD) family of transcription factors, the major partner of YAP1. Mechanistically, the interaction of YAP1/TEADs with AP-1 and cooperation on downstream gene transcription were confirmed, and RANKL-induced NF-κB signaling was also impaired in the YAP1-inhibited condition. Our results revealed the essential role of YAP1 and the YAP1-TEADs complex in regulating osteoclastogenesis and related gene expression.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  AP-1; NF-κB; Osteoclast; TEADs; YAP1

Mesh:

Substances:

Year:  2018        PMID: 29432919     DOI: 10.1016/j.bone.2018.01.035

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  16 in total

1.  The Hippo pathway effectors YAP and TAZ interact with EGF-like signaling to regulate expansion-related events in bovine cumulus cells in vitro.

Authors:  Júlia Koch; Valério Marques Portela; Esdras Corrêa Dos Santos; Daniele Missio; Leonardo Guedes de Andrade; Zigomar da Silva; Bernardo Garziera Gasperin; Alfredo Quites Antoniazzi; Paulo Bayard Dias Gonçalves; Gustavo Zamberlam
Journal:  J Assist Reprod Genet       Date:  2022-01-29       Impact factor: 3.412

Review 2.  The Role of TAK1 in RANKL-Induced Osteoclastogenesis.

Authors:  Wu Jianwei; Tian Ye; Wang Hongwei; Li Dachuan; Zou Fei; Jiang Jianyuan; Wang Hongli
Journal:  Calcif Tissue Int       Date:  2022-03-14       Impact factor: 4.000

Review 3.  YAP/TAZ upstream signals and downstream responses.

Authors:  Antonio Totaro; Tito Panciera; Stefano Piccolo
Journal:  Nat Cell Biol       Date:  2018-07-26       Impact factor: 28.824

4.  TAZ inhibits osteoclastogenesis by attenuating TAK1/NF-κB signaling.

Authors:  Wanlei Yang; Xuanyuan Lu; Tan Zhang; Weiqi Han; Jianlei Li; Wei He; Yewei Jia; Kangxian Zhao; An Qin; Yu Qian
Journal:  Bone Res       Date:  2021-07-12       Impact factor: 13.567

5.  Effects of Taxifolin on Osteoclastogenesis in vitro and in vivo.

Authors:  Cong Cai; Changyu Liu; Liming Zhao; Hui Liu; Weijin Li; Hanfeng Guan; Libo Zhao; Jun Xiao
Journal:  Front Pharmacol       Date:  2018-11-12       Impact factor: 5.810

6.  Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.

Authors:  Sarah A Smith; Richard B Sessions; Deborah K Shoemark; Christopher Williams; Reza Ebrahimighaei; Madeleine C McNeill; Matthew P Crump; Tristan R McKay; Gemma Harris; Andrew C Newby; Mark Bond
Journal:  J Med Chem       Date:  2019-01-31       Impact factor: 7.446

7.  Ovulatory signals alter granulosa cell behavior through YAP1 signaling.

Authors:  Tianyanxin Sun; Francisco J Diaz
Journal:  Reprod Biol Endocrinol       Date:  2019-12-28       Impact factor: 5.211

Review 8.  Yes-Associated Protein 1: Role and Treatment Prospects in Orthopedic Degenerative Diseases.

Authors:  Wenqing Xie; Wenfeng Xiao; Kun Tang; Liyang Zhang; Yusheng Li
Journal:  Front Cell Dev Biol       Date:  2020-10-15

Review 9.  The Hippo Pathway in Innate Anti-microbial Immunity and Anti-tumor Immunity.

Authors:  Qian Zhang; Ruyuan Zhou; Pinglong Xu
Journal:  Front Immunol       Date:  2020-08-04       Impact factor: 7.561

Review 10.  Heterogeneity and Actin Cytoskeleton in Osteoclast and Macrophage Multinucleation.

Authors:  Jiro Takito; Masanori Nakamura
Journal:  Int J Mol Sci       Date:  2020-09-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.